5-氨基-[1,1'-联苯]-2-醇
|
A665260-50mg
|
≥98% |
19434-42-5 |
50mg
|
¥ 79.9
|
期货,请咨询 |
阿拉丁 |
4-乙酰胺基 苯甲酰氯
|
A665233-200mg
|
≥95% |
16331-48-9 |
200mg
|
¥ 199.9
|
现货 |
阿拉丁 |
2-氨基-4,6(1H,5H)-嘧啶二酮
|
A665222-20g
|
≥95% |
4425-67-6 |
20g
|
¥ 39.9
|
现货 |
阿拉丁 |
3-(3-氨基苯基)吡啶
|
A665154-50mg
|
≥95% |
57976-57-5 |
50mg
|
¥ 49.9
|
现货 |
阿拉丁 |
3-(3-氨基苯基)吡啶
|
A665154-200mg
|
≥95% |
57976-57-5 |
200mg
|
¥ 139.9
|
现货 |
阿拉丁 |
(R)-2-氨基-2-(4-氯苯基)乙醇
|
A665072-50mg
|
≥95% |
1067658-27-8 |
50mg
|
¥ 999.9
|
现货 |
阿拉丁 |
alpha-Cyano-4-methoxycinnamic acid
|
A665059-1g
|
≥98% |
1519-55-7 |
1g
|
¥ 299.9
|
现货 |
阿拉丁 |
ATTO 647
|
A665026-5-5mg
|
|
N/A |
5mg
|
¥ 13568.9
|
现货 |
阿拉丁 |
ATTO 647
|
A665026-5-1mg
|
|
N/A |
1mg
|
¥ 3392.9
|
现货 |
阿拉丁 |
Angiotensin II (3-8), human
|
A665024-5mg
|
≥98% |
12676-15-2 |
5mg
|
¥ 79.9
|
现货 |
阿拉丁 |
ATTO Rho14
|
A665016-04-5mg
|
|
N/A |
5mg
|
¥ 10752.9
|
期货,请咨询 |
阿拉丁 |
ATTO Rho14
|
A665016-04-1mg
|
|
N/A |
1mg
|
¥ 2688.9
|
期货,请咨询 |
阿拉丁 |
碱性过硫酸钾溶液
|
A664973-500ml
|
NaOH(ACS 97%):1.5%,K2O8S2(GR):4% |
N/A |
500ml
|
¥ 479.9
|
期货,请咨询 |
阿拉丁 |
ATTO 655
|
A664947-10-5mg
|
|
N/A |
5mg
|
¥ 13568.9
|
期货,请咨询 |
阿拉丁 |
ATTO 655
|
A664947-10-1mg
|
|
N/A |
1mg
|
¥ 3392.9
|
期货,请咨询 |
阿拉丁 |
ATTO 700
|
A664896-9-5mg
|
|
N/A |
5mg
|
¥ 13568.9
|
期货,请咨询 |
阿拉丁 |
ATTO 700
|
A664896-9-1mg
|
|
N/A |
1mg
|
¥ 3392.9
|
期货,请咨询 |
阿拉丁 |
ATTO 610
|
A664892-04-5mg
|
|
N/A |
5mg
|
¥ 7728.9
|
期货,请咨询 |
阿拉丁 |
ATTO 610
|
A664892-04-1mg
|
|
N/A |
1mg
|
¥ 1932.9
|
期货,请咨询 |
阿拉丁 |
ATTO Rho101
|
A664816-05-5mg
|
|
N/A |
5mg
|
¥ 10752.9
|
期货,请咨询 |
阿拉丁 |
ATTO Rho101
|
A664816-05-1mg
|
|
N/A |
1mg
|
¥ 2688.9
|
期货,请咨询 |
阿拉丁 |
ATTO 565 (tetrazine (MeTet)
|
A664762-10-5mg
|
|
N/A |
5mg
|
¥ 5645.9
|
期货,请咨询 |
阿拉丁 |
ATTO 565 (tetrazine (MeTet)
|
A664762-10-1mg
|
|
N/A |
1mg
|
¥ 1411.9
|
期货,请咨询 |
阿拉丁 |
ATTO Rho6G
|
A664743-07-5mg
|
|
N/A |
5mg
|
¥ 10752.9
|
期货,请咨询 |
阿拉丁 |